Augmented serum levels of the IGF-I/IGF-binding protein-3 ratio in pre-menopausal patients with type I breast cysts

European Journal of Endocrinology

Volumn 148, Issue 2, 2003, Pages 177-184

  Enriori, Pablo J ^a   Fischer, Carlos R ^b   Gori, Jorge R ^b   Etkin, Alberto E ^c   Calandra, Ricardo S ^a,d   Lüthy, Isabel A ^a  

^a INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^b HOSPITAL ALEMÁN   (Argentina)

^c HOSPITAL DURAND   (Argentina)

^d UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; BREAST CANCER; BREAST CYST; CANCER RISK; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE CLASSIFICATION; ESTROGEN BLOOD LEVEL; FEMALE; HIGH RISK POPULATION; HUMAN; IMMUNORADIOMETRIC ASSAY; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL ANALYSIS;

ADULT; BREAST DISEASES; CYSTS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; PREMENOPAUSE;

EID: 0037296418     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1480177     Document Type: Article

References (31)

1. Haagensen CD, Bodian C & Haagensen DE Jr (Eds). Gross cystic disease of the breast. In Breast Carcinoma: Risk and Detection, pp 55-75. Philadelphia: W B Saunders, 1981.
2. Zanardi S, Pensa F, Torrisi R, De Franchis V, Barreca A, Minuto F et al. Presence and distribution of growth factors in breast cyst fluid. Annals of the New York Academy of Sciences 1996 784 542-549.
3. Bradlow HL, Rosenfeld RS, Kream J, Fleisher M, O'Connor J & Schwartz MK. Steroid hormone accumulation in human breast cyst fluid. Cancer Research 1981 41 105-107.
4. Bélanger A, Caron S, Labrie F, Naldoni C, Dogliotti L & Angeli A. Levels of eighteen non conjugated and conjugated steroids in human breast cyst fluid: relationships with cyst type. European Journal of Cancer 1990 16 277-281.
5. Enriori CL, Novelli JE, Cremona MC, Hirsig RJP & Enriori PJ. Biochemical study of cyst fluid in human breast cystic disease: a review. Breast Cancer Research and Treatment 1992 24 1-9.
6. Dogliotti L, Orlandi F, Caraci P, Puligheddu B, Torta M & Angeli A. Biochemistry of breast cyst fluid: an approach to understanding intercellular communication in the terminal duct lobular units. Annals of the New York Academy of Sciences 1990 586 17-28.
7. Dixon JM, McDonald C, Elton RA & Miller WR. Risk of breast cancer in women with palpable breast cysts: a prospective study. Lancet 1999 353 1742-1745.
8. Bruzzi P, Dogliotti L, Naldoni C, Bucchi L, Constantini M, Cicognani A et al. Cohort study of association of risk of breast cancer with cyst type in women with gross cystic disease of the breast. British Medical Journal 1997 314 925-928.
9. Bodian CA. Benign breast diseases, carcinoma in situ, and breast cancer risk. Epidemiological Reviews 1993 15 177-187.
10. Angeli A, Dogliotti L, Naldoni L, Puligheddu B, Caraci P, Bucchi L et al. Steroid biochemistry and categorization of breast cyst fluid: relation to breast cancer risk. Journal of Steroid Biochemistry and Molecular Biology 1994 49 333-339.
11. Yu H & Rohan T. Role of the insulin-like growth factor family in cancer development and progression. Journal of the National Cancer Institute 2000 92 1472-1489.
12. Dubaquié Y, Mortensen DL, Intintoli A, Hogue DA, Nakamura G, Rancatore P et al. Binding protein-3-selective insulin-like growth factor I variants: engineering, biodistributions, and clearance. Endocrinology 2001 142 165-173.
13. Peyrat JP, Bonneterre J, Hecquet B, Vennin P, Louchez MM, Fournier C et al. Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer. European Journal of Cancer 1993 29 492-497.
14. Kaulsay KK, Ng EH, Ji CY, Ho GH, Aw TC & Lee K-O. Serum IGF-I binding protein-6 and prostate specific antigen in breast cancer. European Journal of Endocrinology 1999 140 164-168.
15. Bruning PF, Van Doorn J, Bonfrer JM, Van Noord PA, Korse CM, Linders TC et al. Insulin-like growth factor-binding protein-3 is decreased in early-stage operable pre-menopausal breast cancer. International Journal of Cancer 1995 62 266-270.
16. Bohlke K, Cramer DW, Trichopoulos D & Mantzoros CS. Insulin-like growth factor-I in relation to pre-menopausal ductal carcinoma in situ of the breast. Epidemiology 1998 9 570-573.
17. Ng EH, Ji CY, Tan PH, Lin V, Soo KC & Lee OK. Altered serum levels of insulin-like growth factor-binding proteins in breast cancer patients. Annals of Surgical Oncology 1998 5 194-201.
18. Del Giudice ME, Fantus IG, Ezzat S, McKeownn-Eyssen G, Page D & Goodwin PJ. Insulin and related factors in pre-menopausal breast cancer risk. Breast Cancer Research and Treatment 1998 47 111-120.
19. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998 351 1393-1396.
20. Toniolo P, Bruning PF, Akhmedkhanov A, Bonfrer JMG, Koening KL, Lukanova A et al. Serum insulin-like growth factor-I and breast cancer. International Journal of Cancer 2000 88 828-832.
21. Li BDL, Khosravi MJ, Berkel HJ, Diamandi A, Dayton MA, Smith M et al. Free insulin-like growth factor-I and breast cancer risk. International Journal of Cancer 2001 91 736-739.
22. Leiss PH Jr. Gross breast cyst: significance of apocrine type, identification by cyst fluid analysis and management. Breast Disease 1993 6 185-194.
23. Metcalf MG, Donald RA & Livesey JH. Pituitary-ovarian function in normal women during the menopausal transition. Clinical Endocrinology 1981 14 245-255.
24. Dowdy S & Wearden S. Statistics for Research, pp 243-286. New York: John Wiley & Sons, 1983.
25. Boccardo F, Marenghi C, Ghione G, Pepe A, Parodi S & Rubagotti A. Intracystic epidermal growth factor level is predictive of breast-cancer risk in women with gross cystic disease of the breast. International Journal of Cancer (Predictive Oncology) 2001 95 260-265.
26. Ferry RJ, Bingrong L & Cohen P. New roles for IGF binding proteins. Endocrinologist 1999 9 438-450.
27. Blum W, Albertsson-Wikland K, Rosberg S & Ranke MB. Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. Journal of Clinical Endocrinology and Metabolism 1993 76 1610-1616.
28. Juul A, Main K, Blum W, Lindhom J, Ranke MB & Skakkebaek NE. The ratio between levels of insulin-like growth factor (IGF-I) and the IGF binding proteins (IGFBP-1, 2, and 3) decreases with age in healthy adults and is increased in acromegalic patients. Clinical Endocrinology 1994 41 85-93.
29. Harrela M, Koistinen H, Kaprio J, Lehtovirta M, Tuomilehto J, Eriksson J et al. Genetic and environmental components of inter-individual variation in circulating levels of IGF-I, IGF-II, IGFBP-1 and IGFBP-3. Journal of Clinical Investigation 1996 98 2612-2615.
30. Jernstrom H, Deal C, Wilkin F, Chu W, Tao Y, Majeed N et al. Genetic and nongenetic factors associated with variation of plasma levels of Insulin-like Growth Factor-I and Insulin-like Growth Factor-Binding Protein-3 in healthy premenopausal women. Cancer Epidemiology, Biomarkers and Prevention 2001 10 377-384.
31. Ovesen P, Vahl N, Fisker S, Veldhuis JD, Sandahl J, Christiansen JS et al. increased pulsatile, but not basal, growth hormone secretion rates and plasma insulin-like growth factor I levels during the periovulatory interval in normal women. Journal of Clinical Endocrinology and Metabolism 1998 83 1662-1667.